Authors' objectives: The aim of this EUnetHTA Rolling Collaborative Review is 1) to inform health policy at the national/regional and at the European level at an early stage in the life-cycle of therapies which interventions are currently undergoing clinical trials, 2) to monitor (ongoing studies and their results) permanently - in the format of a Living Document - potential therapies against covid-19, 3) to present comparative data on effectiveness and safety of potential therapies, and 4) to support preparations for an evidence-based purchasing of regional/ national health politicians, if necessary. To avoid redundancies and duplication, the EUnetHTA Rolling Collaborative Review will reuse sources from international initiatives to collect information and data on Covid-19 treatments. The scope of the Rolling Collaborative Review is of descriptive nature. These EUnetHTA Rolling Collaborative Reviews are not meant to substitute a joint Relative Effectiveness Assessment (REA) adhering to the agreed procedures and aiming at critical appraisal of the clinical evidence base.

Authors' methods: This Rolling Collaborative Review is prepared according to the project plan (“Rolling Collaborative Review (RCR) on Covid-19 treatments: Project description and planning”, published on the EUnetHTA website) and will be updated monthly. Monthly updates are published on the EUnetHTA Covid-19 Website (https://eunethta.eu/services/covid-19/) and on the EUnetHTA Rolling Collaborative Review Sharepoint page each 15th of the month.

Project Status: Completed

Year Published: 2020

URL for published report: https://eunethta.eu/rcr02/

Requestor: HTA agencies, clinical guideline developers, decision-makers

URL for additional information: https://eunethta.eu/services/covid-19/

English language abstract: An English language summary is available

Publication Type: Rapid Review

Organisation Name: European Network for Health Technology Assessment

Contact Email: eunethta@zinl.nl

Copyright: CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.